Health economic evaluation of bivalirudin in the management of patients undergoing percutaneous coronary intervention in Belgium

被引：0
|
作者：
Ethgen, O
Lamotte, M
Annemans, L
机构：
[1] Univ Liege, Liege, Belgium
[2] HEDM IMS Hlth, Brussels, Belgium
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)67173-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A11 / A11
页数：1
相关论文
共 50 条
  • [31] Economic Evaluation of Complete Revascularization for Patients with Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention
    Barton, Garry R.
    Irvine, Lisa
    Flather, Marcus
    McCann, Gerry P.
    Curzen, Nick
    Gershlick, Anthony H.
    VALUE IN HEALTH, 2017, 20 (06) : 745 - 751
  • [32] Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: Economic Considerations
    William S. Weintraub
    Leonid Mandel
    Sandra A. Weiss
    PharmacoEconomics, 2013, 31 : 959 - 970
  • [33] Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention: Economic Considerations
    Weintraub, William S.
    Mandel, Leonid
    Weiss, Sandra A.
    PHARMACOECONOMICS, 2013, 31 (11) : 959 - 970
  • [34] Bivalirudin is associated with improved clinical and economic outcomes in heart failure patients undergoing percutaneous coronary intervention: Results from an observational database
    Pinto, Duane S.
    Kohli, Payal
    Fan, Weihong
    Kirtane, Ajay J.
    Kociol, Robert D.
    Meduri, Christopher
    Deliargyris, Efthymios N.
    Prats, Jayne
    Reynolds, Matthew R.
    Stone, Gregg W.
    Gibson, C. Michael
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2016, 87 (03) : 361 - 373
  • [35] A meta-analysis of bivalirudin compared with unfractionated heparin in patients with acute coronary syndromes undergoing urgent percutaneous coronary intervention versus elective percutaneous coronary intervention
    Liu, Yulong
    Li, Liang
    Wang, Mei
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (16) : C111 - C111
  • [36] BUDGET IMPACT OF BIVALIRUDIN IN STEMI PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION (PPCI) IN GERMAN HOSPITALS
    Olchanski, N.
    Slawsky, K.
    Cyr, P.
    Schwenkglenks, M.
    Zeymer, U.
    VALUE IN HEALTH, 2010, 13 (03) : A157 - A157
  • [37] BUDGET IMPACT OF BIVALIRUDIN IN STEMI PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION (PPCI) IN UK HOSPITALS
    Olchanski, N.
    Slawsky, K.
    Cyr, P. L.
    Schwenkglenks, M.
    Kinnaird, T.
    VALUE IN HEALTH, 2009, 12 (07) : A321 - A321
  • [38] Safety and Effectiveness of Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis
    Hamdi, Abdul Hafeez Ahmad
    Dali, Ahmad Fauzi
    Nuri, Thimarul Huda Mat
    Saleh, Muhammad Syafiq
    Ajmi, Noor Nabila
    Neoh, Chin Fen
    Ming, Long Chiau
    Abdullah, Amir Heberd
    Khan, Tahir Mehmood
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [39] Regulation of PAR-1 in patients undergoing percutaneous coronary intervention: effects of unfractionated heparin and bivalirudin
    Eslam, Roza Badr
    Reiter, Nina
    Kaider, Alexandra
    Eichinger, Sabine
    Lang, Irene M.
    Panzer, Simon
    EUROPEAN HEART JOURNAL, 2009, 30 (15) : 1831 - 1836
  • [40] Efficacy and Safety of Bivalirudin in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention in Current Clinical Practice
    Kim, Luke K.
    Wong, S. Chiu
    Minutello, Robert M.
    Bergman, Geoffrey
    Feldman, Dmitriy N.
    JOURNAL OF INVASIVE CARDIOLOGY, 2010, 22 (03): : 94 - 100
12345